The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly.Top 5 Upgrades: BMO Capital upgraded Southwest (LUV) to Outperform from Market Perform with a price target of $57.50, up from $43. The airline's current initiatives offer "significant momentum" and earnings upside to at least $4.00 per share in 2026 from 93c in 2025, the firm tells investors in a research note.Barclays upgraded Q ...

Jefferies set a price target of $18 for Kenvue Inc. (NYSE: KVUE), indicating a potential upside of about 4.65%.The consensus rating among eighteen brokerages is a "Hold," with an average 1-year target price of $20.23.Recent analyst reports show mixed sentiments, with price targets ranging from $15.00 to $20.00.Kenvue Inc. (NYSE: KVUE) is a prominent player in the consumer health industry, known for its wide range of health and wellness products. The company operates in a competitive market, with rivals like ...

Jefferies downgrades Kenvue Inc. (NYSE: KVUE) from Buy to Hold, indicating a cautious outlook.The average 1-year target price among analysts is set at approximately $20.23.Other financial institutions like Citigroup and Canaccord Genuity Group have also revised their price targets and ratings, reflecting a tempered view on Kenvue's future performance.Kenvue Inc. (NYSE: KVUE) is a prominent player in the consumer health industry, offering a range of products that cater to personal health and wellness. The co ...

Financial Data and Key Metrics Changes - Kenvue's special meeting of stockholders was convened with a quorum of 1,499,451,317 shares, representing 78.2% by proxy [3] - The merger proposal was approved by a majority of voting power of capital stock present [6] Business Line Data and Key Metrics Changes - The meeting included discussions on the Merger Agreement with Kimberly-Clark, which was deemed fair and in the best interest of Kenvue and its stockholders [4] Market Data and Key Metrics Changes - No specific market data or key metrics were provided in the meeting records Company Strategy and Development Direction - The Kenvue Board of Directors unanimously recommended approval of the Merger Proposal, indicating a strategic move towards consolidation with Kimberly-Clark [4][5] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the merger's benefits for Kenvue and its stockholders, highlighting the importance of the transaction [4] Other Important Information - The Advisory Compensation Proposal related to the merger was also approved by stockholders [7] Q&A Session Summary - No specific questions or answers were recorded during the meeting, as it primarily focused on the proposals and their approvals [7]

Kenvue (NYSE:KVUE) FY 2026 Annual General Meeting January 29, 2026 09:00 AM ET Company ParticipantsLarry Merlo - Chair of the Board of DirectorsTeddy Reed - VP and Corporate SecretaryOperator...Welcome to the Kenvue Inc. special meeting of stockholders. I'd now like to introduce Larry Merlo, Chair of Kenvue's Board of Directors.Larry MerloMy pleasure to welcome you to Kenvue's special meeting of stockholders. I'm Larry Merlo, Chair of Kenvue's Board of Directors, and I will chair this special meeting. It is ...

Financial Data and Key Metrics Changes - Kenvue's special meeting confirmed the approval of the Merger Proposal, indicating a significant strategic move for the company [4][6] - The Advisory Compensation Proposal was also approved, reflecting shareholder support for management's compensation related to the merger [6] Business Line Data and Key Metrics Changes - No specific data on individual business lines was provided in the meeting [1][2] Market Data and Key Metrics Changes - The meeting did not present detailed market data or metrics [1][2] Company Strategy and Development Direction - The company is pursuing a merger with Kimberly-Clark, which is seen as beneficial for Kenvue and its shareholders [4][5] - The board unanimously recommended the merger, indicating a strong strategic alignment with Kimberly-Clark [5] Management Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during this meeting [1][2] Other Important Information - The meeting was conducted with a quorum of 78.2% of shares represented, ensuring that decisions made were valid [3] - The final vote results will be reported in a current report on Form 8-K filed with the SEC [6] Q&A Session Summary - There were no questions or answers recorded during this special meeting [1][2]

Core Viewpoint - Kimberly-Clark Corporation and Kenvue Inc. have received overwhelming shareholder approval for Kimberly-Clark's acquisition of Kenvue, marking a significant step towards creating a global health and wellness leader [1][2]. Group 1: Transaction Details - The acquisition transaction is expected to close in the second half of 2026, pending regulatory approvals and other customary closing conditions [3]. - Approximately 96% of shares present at Kimberly-Clark's Special Meeting voted in favor of the share issuance related to the transaction [2]. - At Kenvue's Special Meeting, about 99% of shares voted to adopt the merger agreement, representing approximately 77% of all outstanding shares [2]. Group 2: Company Statements - Kimberly-Clark's CEO, Mike Hsu, expressed gratitude to shareholders for their support and emphasized the potential to raise care standards for billions globally while generating significant shareholder value [2]. - Kenvue's CEO, Kirk Perry, highlighted the growth opportunities for the combined company and the potential to accelerate innovation and expand access to trusted brands [2]. Group 3: Company Backgrounds - Kimberly-Clark operates in over 175 countries with a portfolio of brands that hold No. 1 or No. 2 market share positions in approximately 70 countries, focusing on sustainable practices [4]. - Kenvue is recognized as the world's largest pure-play consumer health company by revenue, with a heritage of over a century and a portfolio of well-known brands [5].

Kenvue (KVUE) shareholders will vote on Kimberly-Clark's (KMB) $48.7 billion acquisition proposal on Thursday, Jan. 29. The merge deal, announced in November 2025, would create a consumer health and wellness powerhouse, combining iconic brands like Band-Aid, Tylenol, and Listerine with Huggies, Kleenex, and Cottonelle. The transaction offers shareholders $21.01 per share in total consideration, representing a meaningful premium over current trading levels of around $17. Yet with KVUE stock trading roughl ...

Valued at a market cap of $33.5 billion, Kenvue Inc. (KVUE) is a consumer health company based in Summit, New Jersey. It focuses on developing, manufacturing, and marketing everyday health, personal care, and wellness products. This personal care company has lagged behind the broader market over the past 52 weeks. Shares of KVUE have declined 18.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 16.1%. Moreover, on a YTD basis, the stock is up 1.5%, compared to SPX’s 1.9% return. ...

Core Viewpoint - Kimberly-Clark reported a higher profit in its latest quarter just days before shareholders vote on its plan to buy Kenvue, aiming to create a global health-and-wellness giant [1] Financial Performance - The company achieved a higher profit in its latest quarter, indicating strong financial performance [1] Strategic Move - The planned acquisition of Kenvue is designed to enhance Kimberly-Clark's position in the health-and-wellness sector, reflecting a strategic initiative to expand its market presence [1]